A neuroimaging biomarker for disease staging in clinically diagnosed Alzheimer's disease
{{output}}
Background: Precision medicine for Alzheimer's disease (AD) requires the development of a robust management framework grounded in individualized disease staging systems. To date, only a limited number of studies have supplemente... ...
